CD8A and neoplasm: It is tempting to speculate that high MICA/B production by the neoplastic HRS cells of cHL upon SFN treatment may promote anti-tumor immune responses through activation of the NK and CD8+ T- and NK cells in the TME resulting in tumor cell killing.